Clinical trial
Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects
NCT01229423 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects
- Lead sponsor
- Allergan
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- October 31, 2010
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
eyelash hypotrichosis